UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (1249) 1249
life sciences & biomedicine (1218) 1218
humans (1202) 1202
male (659) 659
antifungal agents - therapeutic use (653) 653
female (598) 598
infectious diseases (591) 591
middle aged (498) 498
aspergillosis (470) 470
invasive aspergillosis (470) 470
mycoses (465) 465
adult (415) 415
aged (358) 358
microbiology (331) 331
invasive pulmonary aspergillosis - drug therapy (317) 317
antifungal agents (285) 285
risk factors (283) 283
health aspects (272) 272
mycology (250) 250
treatment outcome (242) 242
mortality (237) 237
retrospective studies (237) 237
immunocompromised host (236) 236
transplantation (233) 233
invasive pulmonary aspergillosis (232) 232
aspergillosis - drug therapy (228) 228
invasive pulmonary aspergillosis - diagnosis (224) 224
hematology (221) 221
biological and medical sciences (220) 220
antifungal agents - administration & dosage (217) 217
invasive fungal infection (216) 216
pharmacology & pharmacy (213) 213
medical sciences (212) 212
adolescent (209) 209
voriconazole (206) 206
fungal infections (205) 205
diagnosis (194) 194
aspergillus (186) 186
immunology (182) 182
care and treatment (179) 179
patients (174) 174
young adult (168) 168
child (167) 167
invasive pulmonary aspergillosis - microbiology (167) 167
animals (166) 166
neutropenia (155) 155
invasive fungal infections (147) 147
fungi (144) 144
triazoles - therapeutic use (144) 144
medicine & public health (139) 139
oncology (138) 138
mycoses - drug therapy (133) 133
antifungal agents - pharmacology (131) 131
research (131) 131
pulmonary aspergillosis (125) 125
cancer (124) 124
amphotericin b (123) 123
dermatology (120) 120
chemotherapy (119) 119
leukemia (118) 118
aspergillosis - diagnosis (116) 116
infections (115) 115
epidemiology (114) 114
aged, 80 and over (113) 113
galactomannan (112) 112
amphotericin b - therapeutic use (111) 111
human mycoses (111) 111
invasive fungal disease (111) 111
analysis (109) 109
aspergillosis - microbiology (109) 109
internal medicine (109) 109
aspergillus fumigatus (108) 108
stem cells (107) 107
pediatrics (105) 105
echinocandins - therapeutic use (103) 103
general & internal medicine (102) 102
prophylaxis (102) 102
antifungal agents - adverse effects (101) 101
invasive fungal infections - drug therapy (100) 100
aspergillus - isolation & purification (97) 97
child, preschool (95) 95
tomography, x-ray computed (95) 95
drug therapy, combination (92) 92
hematopoietic stem cells (92) 92
transplants & implants (88) 88
hematologic neoplasms - complications (87) 87
posaconazole (86) 86
infection (85) 85
drug therapy (84) 84
incidence (84) 84
pharmacology. drug treatments (84) 84
candidiasis (82) 82
caspofungin (82) 82
mannans - blood (82) 82
medical research (82) 82
antifungal agents - pharmacokinetics (81) 81
hematopoietic stem cell transplantation (80) 80
medicine (80) 80
aspergillus fumigatus - drug effects (79) 79
aspergillus fumigatus - isolation & purification (78) 78
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1724) 1724
German (49) 49
Spanish (13) 13
Japanese (11) 11
French (10) 10
Chinese (7) 7
Portuguese (5) 5
Russian (2) 2
Polish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The European respiratory journal, ISSN 0903-1936, 01/2016, Volume 47, Issue 1, pp. 45 - 68
Journal Article
Respiratory medicine, ISSN 0954-6111, 08/2018, Volume 141, pp. 121 - 131
Aspergillus | Chronic pulmonary aspergillosis | Invasive aspergillosis | Pulmonary aspergillosis | Allergic bronchopulmonary aspergillosis | Cardiac & Cardiovascular Systems | Respiratory System | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Invasive Pulmonary Aspergillosis - drug therapy | Recurrence | Triazoles - administration & dosage | Pulmonary Aspergillosis - drug therapy | Prognosis | Pyridines - administration & dosage | Humans | Environmental Exposure - prevention & control | Pulmonary Aspergillosis - diagnosis | Aspergillosis, Allergic Bronchopulmonary - drug therapy | Pulmonary Aspergillosis - microbiology | Invasive Pulmonary Aspergillosis - diagnosis | Antifungal Agents - therapeutic use | Environmental Exposure - adverse effects | Fungi | Nitriles - administration & dosage | Pulmonary Aspergillosis - epidemiology | Aspergillus - isolation & purification | Aspergillosis, Allergic Bronchopulmonary - diagnosis | Nitriles - therapeutic use | Pyridines - therapeutic use | Triazoles - therapeutic use | Sleep disorders | Medical colleges | Triazoles | Communicable diseases | Cystic fibrosis | Respiratory agents | Drug approval | Risk factors | Therapy | Regulatory agencies | Medical imaging | Microbiology | Mycology | Medical treatment | Molds | Infections | Medical diagnosis | Patients | Asthma | Infectious diseases | Classification | Aspergillosis | Chronic obstructive pulmonary disease | Diagnosis | Clinical microbiology | Immune system | Index Medicus
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 5/2011, Volume 52, Issue 9, pp. 1123 - 1129
Polymerase chain reaction | Antifungals | Aspergillus | Azoles | Triazoles | Aspergillosis | Sputum | ARTICLES AND COMMENTARIES | Allergic bronchopulmonary aspergillosis | Aspergillus fumigatus | Genetic mutation | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Biological and medical sciences | Infectious diseases | Medical sciences | Aspergillus fumigatus - drug effects | Sputum - microbiology | Lung - microbiology | Aspergillosis, Allergic Bronchopulmonary - microbiology | Humans | Aspergillosis, Allergic Bronchopulmonary - drug therapy | Antifungal Agents - therapeutic use | Bronchoalveolar Lavage Fluid - microbiology | Aspergillus fumigatus - isolation & purification | Culture Media | Polymerase Chain Reaction | Aspergillosis, Allergic Bronchopulmonary - epidemiology | Invasive Pulmonary Aspergillosis - epidemiology | Triazoles - therapeutic use | Antifungal Agents - pharmacology | Invasive Pulmonary Aspergillosis - drug therapy | Pulmonary Aspergillosis - drug therapy | DNA, Fungal - analysis | Drug Resistance, Fungal - genetics | Aspergillus fumigatus - genetics | Pulmonary Aspergillosis - microbiology | Triazoles - pharmacology | Pulmonary Aspergillosis - epidemiology | Invasive Pulmonary Aspergillosis - microbiology | Mutation | Chronic Disease | Drug resistance in microorganisms | Usage | Physiological aspects | Causes of | Lung diseases, Fungal | Research | Drug therapy | Health aspects | Fungi | Medical diagnosis | Deoxyribonucleic acid--DNA | Nonnative species | Polymorphism | Index Medicus | and Commentaries
Journal Article
Clinical microbiology and infection, ISSN 1198-743X, 12/2011, Volume 17, Issue 12, pp. 1882 - 1889
invasive aspergillosis | voriconazole | galactomannan | Epidemiology | outcome | Galactomannan | Invasive aspergillosis | Outcome | Voriconazole | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Human mycoses | Infectious diseases | Pharmacology. Drug treatments | Antifungal agents | Mycoses | Biological and medical sciences | Medical sciences | Miscellaneous mycoses | Antibiotics. Antiinfectious agents. Antiparasitic agents | Aspergillus - classification | Prospective Studies | Humans | Middle Aged | Male | Antifungal Agents - therapeutic use | Incidence | Young Adult | Aged, 80 and over | Aspergillus - isolation & purification | Adult | Female | Seasons | Invasive Pulmonary Aspergillosis - epidemiology | Invasive Pulmonary Aspergillosis - drug therapy | France - epidemiology | Risk Factors | Invasive Pulmonary Aspergillosis - mortality | Drug Therapy, Combination - methods | Hospitals | Invasive Pulmonary Aspergillosis - microbiology | Mannans - blood | Adolescent | Aged | Immunocompromised Host | Analysis | Leukemia | Aspergillosis | Stem cells | Transplantation of organs, tissues, etc | Respiratory tract diseases | Transplantation | Risk factors | Trends | Transplants & implants | Mortality | Cell culture | Risk groups | Lung | stem cell transplantation | Central nervous system | Immunoproliferative diseases | Lipids | Regression analysis | Inflammatory diseases | Seasonal variations | Caspofungin | Geriatrics | Tumors | Index Medicus | Life Sciences | Aspergillus | Microbiology and Parasitology | Invasive Pulmonary Aspergillosis | Mannans | Antifungal Agents | Drug Therapy, Combination | France
Journal Article
Clinical microbiology and infection, ISSN 1198-743X, 05/2018, Volume 24, pp. e1 - e38
Journal Article